<p>Demand is increasing for Daikyo&rsquo;s sterile, ready to use closure components, known as Daikyo RUV&reg; (Ready to Use Validated) components. Against that background, Daikyo has significantly expanded its packaging component sterilization operations to meet the needs of smaller customers as well as large scale pharmaceutical companies. By adopting an approach that replicates its existing footprint, Daikyo has been able to manage validation risks effectively, while meeting an ambitious timeline for bringing on new autoclave capacity. The result of this expansion is a state-of-the-art facility that triples the company&rsquo;s previous sterilization capacity.</p>